These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8529056)

  • 21. Transmitter-like basal and K(+)-evoked release of 3,4-dihydroxyphenylalanine from the striatum in conscious rats studied by microdialysis.
    Nakamura S; Goshima Y; Yue JL; Misu Y
    J Neurochem; 1992 Jan; 58(1):270-5. PubMed ID: 1345766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence that D2 receptor-mediated activation of hypothalamic tuberoinfundibular dopaminergic neurons in the male rat occurs via inhibition of tonically active afferent dynorphinergic neurons.
    Durham RA; Johnson JD; Moore KE; Lookingland KJ
    Brain Res; 1996 Sep; 732(1-2):113-20. PubMed ID: 8891275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary excretion of dihydroxyphenylalanine and dopamine during alterations of dietary salt intake in humans.
    Goldstein DS; Stull R; Eisenhofer G; Gill JR
    Clin Sci (Lond); 1989 May; 76(5):517-22. PubMed ID: 2498027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NSD 1034: an amino acid decarboxylase inhibitor with a stimulatory action on dopamine synthesis not mediated by classical dopamine receptors.
    Nissbrandt H; Engberg G; Wikström H; Magnusson T; Carlsson A
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Aug; 338(2):148-61. PubMed ID: 3141816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Borderline hypertensive autosomal dominant polycystic kidney disease patients have enhanced production of renal dopamine. Normalization of renal haemodynamics by DOPA infusion.
    Barendregt JN; Florijn KW; Muizert Y; Chang PC
    Nephrol Dial Transplant; 1995; 10(8):1332-41. PubMed ID: 8538923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.
    Watanabe AM; Parks LC; Kopin IJ
    J Clin Invest; 1971 Jun; 50(6):1322-8. PubMed ID: 5578236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A specific radioenzymatic assay for dihydroxyphenylalanine (DOPA). Plasma dopa may be the precursor of urine free dopamine.
    Brown MJ; Dollery CT
    Br J Clin Pharmacol; 1981 Jan; 11(1):79-83. PubMed ID: 6783056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uptake and decarboxylation of L-3,4-dihydroxyphenylalanine in cultured monkey placenta amniotic epithelial cells.
    Elwan MA; Sakuragawa N
    Placenta; 2007; 28(2-3):245-8. PubMed ID: 16580727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Renal dopamine synthesis from precursors.
    Barthelmebs M; Vailly B; Velly J; Ehrhardt JD; Grima M; Imbs JL
    Am J Hypertens; 1990 Jun; 3(6 Pt 2):18S-21S. PubMed ID: 2116809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Striatal L-dopa decarboxylase activity in Parkinson's disease in vivo: implications for the regulation of dopamine synthesis.
    Gjedde A; Léger GC; Cumming P; Yasuhara Y; Evans AC; Guttman M; Kuwabara H
    J Neurochem; 1993 Oct; 61(4):1538-41. PubMed ID: 8377003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal response to infusion of dopamine precursors in anaesthetized rats.
    Mühlbauer B; Gleiter CH; Gies C; Luippold G; Löschmann PA
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):838-45. PubMed ID: 9453471
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of dopamine in development of hypertension in spontaneously hypertensive rat: effect of carbidopa, inhibitor of peripheral dopa decarboxylase.
    Yoshimura M; Kambara S; Takahashi H; Okabayashi H; Ijichi H
    Clin Exp Hypertens A; 1987; 9(10):1585-99. PubMed ID: 3677444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms.
    Cumming P; Gjedde A
    Synapse; 1998 May; 29(1):37-61. PubMed ID: 9552174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of administration of dopamine and L-DOPA to dogs on their plasma level of dopamine sulfate.
    Oka M; Ishimura Y; Tsunematsu T; Minakuchi K; Ohuchi T; Matsumoto K
    Biochem Pharmacol; 1987 Oct; 36(19):3205-8. PubMed ID: 3663235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma.
    Kuchel O; Buu NT; Edwards DJ
    J Lab Clin Med; 1990 Apr; 115(4):449-53. PubMed ID: 1969915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sympathoadrenal contribution to plasma dopa (3,4-dihydroxyphenylalanine) in rats.
    Grossman E; Hoffman A; Armando I; Abassi Z; Kopin IJ; Goldstein DS
    Clin Sci (Lond); 1992 Jul; 83(1):65-74. PubMed ID: 1325324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model.
    Soares-da-Silva P; Pestana M; Vieira-Coelho MA; Fernandes MH; Albino-Teixeira A
    Br J Pharmacol; 1995 Apr; 114(7):1403-13. PubMed ID: 7541690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-Tyr-Induced Phosphorylation of Tyrosine Hydroxylase at Ser40: An Alternative Route for Dopamine Synthesis and Modulation of Na+/K+-ATPase in Kidney Cells.
    Taveira-da-Silva R; da Silva Sampaio L; Vieyra A; Einicker-Lamas M
    Kidney Blood Press Res; 2019; 44(1):1-11. PubMed ID: 30808844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The adrenal glands as suppliers of plasma L-Dopa and sources of urinary dopamine.
    Hansell P; Källskog O; Wolgast M
    Kidney Blood Press Res; 1996; 19(2):109-14. PubMed ID: 8871890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopa decarboxylase activity of the living human brain.
    Gjedde A; Reith J; Dyve S; Léger G; Guttman M; Diksic M; Evans A; Kuwabara H
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2721-5. PubMed ID: 1688340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.